Physician profile
Daniel Arndt
NPI 1245499961
$61,949.29
in general payments reported to CMS, 2019-2025
21 companies · $9,462 in 2025
The $9,462 reported for 2025 was more than what 90% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $12K · 2021: $12.60 · 2022: $2,484 · 2023: $231 · 2024: $2,633 · 2025: $9,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,792 · Food and Beverage: $1,919 · Travel and Lodging: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,792.00 |
| Food and Beverage | $1,919.23 |
| Travel and Lodging | $615.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $30,919.00 | 2019 | |
| Livanova USA, INC. | $22,726.05 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Mallinckrodt Hospital Products INC. | $5,700.00 | 2020 | |
| Biomarin Pharmaceutical INC. | $1,071.96 | 2019 | |
| Ucb, INC. | $470.72 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Jazz Pharmaceuticals INC. | $284.57 | 2023-2025 | |
| Neurelis, INC. | $166.73 | 2025 | Valtoco |
| Biocodex, INC. | $130.25 | 2019 | |
| Sunovion Pharmaceuticals INC. | $122.19 | 2019 | |
| Otter Pharmaceuticals, LLC | $70.86 | 2025 | Sympazan |
| Acadia Pharmaceuticals INC | $53.71 | 2025 | Daybue |
| Catalyst Pharmaceuticals, INC. | $47.69 | 2025 | |
| Aucta Pharmaceuticals, INC. | $45.15 | 2025 | Motpoly Xr |
| Upsher-Smith Laboratories LLC | $43.32 | 2025 | |
| Medtronic, INC. | $27.01 | 2025 | Activa Pc |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $22.00 | 2025 | Austedo Xr |
| Alexion Pharmaceuticals, INC. | $19.71 | 2025 | Koselugo |
| Intrabio INC | $15.77 | 2025 | Aqneursa |
| Zogenix INC. | $12.60 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Arndt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.